P Harvey Selected Research

P Harvey Research Topics

2	Hypertension (High Blood Pressure) 08/2018 - 01/2017
2	Heart Diseases (Heart Disease) 08/2018 - 04/2018
2	Infections 01/2017 - 10/2008
2	Mesothelioma 11/2000 - 06/2000
1	Gambling (Pathological Gambling) 12/2019
1	Dyslipidemias (Dyslipidemia) 08/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 08/2018
1	Connective Tissue Diseases (Connective Tissue Disease) 04/2018
1	Cardiomyopathies (Cardiomyopathy) 04/2018
1	Hyperglycemia 01/2017
1	Mobility Limitation (Difficulty Walking) 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2010
1	Fatigue 10/2008
1	Nausea 10/2008
1	Constipation 10/2008
1	Stomatitis 10/2008
1	Breast Neoplasms (Breast Cancer) 10/2008
1	Vomiting 10/2008
1	Alopecia (Baldness) 10/2008
1	Malaria 04/2008
1	Pseudoxanthoma Elasticum (Gronblad Strandberg Syndrome) 01/2003
1	Type 2 Diabetes Mellitus (MODY) 04/2002
1	Weight Loss (Weight Reduction) 04/2002
1	Pathologic Processes 11/2000
1	Neoplasm Metastasis (Metastasis) 11/2000
1	Neoplasms (Cancer) 11/2000
1	Malignant Mesothelioma 06/2000

2	Antimalarials (Antimalarial Agents)IBA 08/2018 - 04/2018
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2000 - 06/2000
1	Retinaldehyde (Retinal)IBA 04/2018
1	candesartanIBA 01/2017
1	ametantrone (HAQ)IBA 01/2017
1	candesartan cilexetil (Amias)FDA Link 01/2017
1	Nifedipine (Adalat)FDA LinkGeneric 01/2017
1	TabletsIBA 07/2010
1	oxidized low density lipoproteinIBA 07/2010
1	Rosuvastatin Calcium (Crestor)FDA Link 07/2010
1	Atorvastatin (Lipitor)FDA Link 07/2010
1	Ezetimibe (Zetia)FDA Link 07/2010
1	Simvastatin (Zocor)FDA LinkGeneric 07/2010
1	Fluorouracil (Carac)FDA LinkGeneric 10/2008
1	Methotrexate (Mexate)FDA LinkGeneric 10/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2008
1	Epirubicin (Ellence)FDA LinkGeneric 10/2008
1	1- (ethoxycarbonyloxymethyl)- 5- fluorouracilIBA 10/2008
1	IronIBA 04/2008
1	Hypoglycemic Agents (Hypoglycemics)IBA 04/2002
1	HDL CholesterolIBA 04/2002
1	Matrix Metalloproteinases (MMPs)IBA 11/2000
1	Protease Inhibitors (Protease Inhibitor)IBA 11/2000
1	Chemotactic FactorsIBA 11/2000
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 11/2000
1	Serine Proteases (Serine Protease)IBA 11/2000
1	ParaffinIBA 06/2000
1	Cadherins (E-Cadherin)IBA 06/2000
1	AntibodiesIBA 06/2000
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2000

2	Therapeutics 12/2019 - 01/2017
1	Kidney Transplantation 08/2018
1	Duration of Therapy 08/2018
1	Surgical Amputation (Amputations) 01/2017
1	Renal Dialysis (Hemodialysis) 01/2017
1	Epidural Analgesia 01/2003
1	Analgesia 01/2003
1	Caloric Restriction 04/2002